Bioactive Compounds
-
BA2287 4-O-MethylbavachalconeSummary: 4'-O-Methylbavachalcone is a chalcone isolated from psoralen. - BA2285 ArbemnifosbuvirSummary: Arbemnifosbuvir is a nucleovirus RdRp-associated nucleotide group transferase (NiRAN) nonstructural protein 12 (nsp12) interfering drug.
- BA2284 BofutrelvirSummary: Bofutrelvir (FB2001) is a major protease inhibitor of SARS-CoV-2.
- BA2283 MM3122Summary: MM3122 is a selective inhibitor of type II transmembrane serine proteases.
- BA2282 YH-53Summary: YH-53 is a potent inhibitor.
- BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
- BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor.
- BA2279 X77Summary: X77 is a potent non-covalent bond inhibitor of the SARS-CoV-2 protease.
- BA2278 rel-ZotatifinSummary: re-Zotatifin is a racemic isomer of Zotatifin and is less active than Zotatifin as an eIF4A inhibitor.
- BA2277 XR8-89Summary: XR8-89 is a potent papain-like inhibitor.